Clinical Trials Logo

Clinical Trial Summary

This is an open-label study evaluating the safety, tolerability, pharmacokinetics, and efficacy of SAGE-217 in the treatment of subjects with bipolar I/II disorder with a current major depressive episode.


Clinical Trial Description

This posting addresses Part A ;


Study Design


Related Conditions & MeSH terms


NCT number NCT03692910
Study type Interventional
Source Sage Therapeutics
Contact Handan Gunduz-Bruce
Phone 617-949-2883
Email handan.gunduz-bruce@sagerx.com
Status Recruiting
Phase Phase 2
Start date August 19, 2018
Completion date September 2019

See also
  Status Clinical Trial Phase
Completed NCT03256162 - Ketamine as an Adjunctive Therapy for Major Depression Phase 1
Not yet recruiting NCT03646058 - Add-on Buprenorphine at Analgesic Doses for the Treatment of Severe Suicidal Ideas During a Major Depressive Episode Phase 3
Active, not recruiting NCT01944293 - Ketamine for Suicidality in Bipolar Depression Phase 1/Phase 2
Recruiting NCT01441505 - A Study of Ketamine as an Antidepressant Phase 2
Recruiting NCT03735576 - Cognitive Behavioural Therapy for the Treatment of Late Life Depression N/A
Recruiting NCT02824081 - Neuroinflammation, Serotonin, Impulsivity and Suicide N/A
Terminated NCT01099592 - Antidepressants to Promote Recovery of Cardiac Patients Suffering From Depression Phase 4
Not yet recruiting NCT03752853 - Stress Systems and Psychotherapy in Depression N/A
Completed NCT03190772 - The Role of Expectations in the Pharmacological Treatment of Depression - An Experimental Investigation N/A
Active, not recruiting NCT02839798 - NeoSync TMS Treatment for Bipolar I Depression Phase 2
Completed NCT00852592 - Light Therapy for Bipolar Disorder. Efficacy of Light Therapy for Bipolar Depression: A Randomized Controlled Trial Phase 3
Not yet recruiting NCT03487926 - Microglial Activation in Inflammatory Bowel Disease
Recruiting NCT02915679 - Pain Perception in Suicidal Behavior Vulnerability N/A
Completed NCT01620502 - N-3 Polyunsaturated Fatty Acids in the Prevention and Treatment for IFN-induced Depression N/A
Completed NCT00998231 - Major Depression and Messenger RNAs N/A
Enrolling by invitation NCT03716869 - Universal vs. Targeted School Screening for Adolescent Major Depressive Disorder N/A
Completed NCT02032576 - Predictors of the Response and Relapse/Recurrence After ECT for Depressed Patients Phase 4
Not yet recruiting NCT03770156 - November 13, 2015 - Continuity of Care
Recruiting NCT02051413 - Beta-arrestins and Response to Venlafaxine in Major Depressive Disorder (MDD) (DEPARRESTCLIN) Phase 4
Completed NCT00237666 - Open-Label Study of Geodon in Non-Rapid Cycling Bipolar II Patients With Major Depression Phase 4